Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Elizabeth C. Moser"'
1
Akademický článek
Cardiovascular disease after cancer therapy
Autor: Berthe M.P. Aleman, Elizabeth C. Moser, Janine Nuver, Thomas M. Suter, Maja V. Maraldo, Lena Specht, Conny Vrieling, Sarah C. Darby
Publikováno v: EJC Supplements, Vol 12, Iss 1, Pp 18-28 (2014)
Improvements in treatment and earlier diagnosis have both contributed to increased survival for many cancer patients. Unfortunately, many treatments carry a risk of late effects including cardiovascular diseases (CVDs), possibly leading to significan
Externí odkaz: https://doaj.org/article/fc78c3dfac054da8a906f88286163492
Zobrazit plný text záznamu
3
GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in Combination with GC4711 in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer (PC)
Autor: James C. Costello, Muhammad Shaalan Beg, Sarah E. Hoffe, Joseph M. Herman, Parag J. Parikh, Mokenge P. Malafa, Elizabeth C. Moser, Dae Won Kim, Todd A. Aguilera, Kara Terry, Jon Holmlund
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 111:e44-e45
TPS4175 Background: While systemic treatment of PC has improved, rates of surgical resection - considered optimum treatment - remain low. Patients with un-resectable or borderline PC still have poor outcomes, with both toxicity and disease progressio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82ecee20154f738d16c9f51daeec36c
https://doi.org/10.1016/j.ijrobp.2021.07.372
Zobrazit plný text záznamu
5
GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) With or Without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC)
Autor: Puneeth Iyengar, Elizabeth C. Moser, Jon Holmlund, Chris R. Kelsey, Bryan G. Allen, M Brookes
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 111:e471
Purpose/objective(s) The number of patients diagnosed with early-stage NSCLC has been increasing with screening programs and more frequent thoracic imaging. Many patients are not ideal surgical candidates and SBRT offers an effective alternative. SBR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41b4b4e0f5e892f82854f2558f2d0fd7
https://doi.org/10.1016/j.ijrobp.2021.07.1313
Zobrazit plný text záznamu
7
Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma
Autor: Umberto Tirelli, Berthe M.P. Aleman, Evert M. Noordijk, José Thomas, Elizabeth C. Moser, Hanneke C. Kluin-Nelemans, Patrice Carde, Martine Van Glabbeke, Joke W. Baars, J.H. Meerwaldt
Publikováno v: International Journal of Radiation Oncology Biology Physics, 66(4), 1168-1177. ELSEVIER SCIENCE INC
Purpose: Whether salvage therapy in patients with advanced aggressive non-Hodgkin's lymphorna (NHL) in partial remission (PR) should consist of radiotherapy or autologous stem-cell transplantation (ASCT) is debatable. We evaluated the impact of radio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6239831ae6e14a2ef532bdd8198c3d
https://research.rug.nl/en/publications/b8d14039-4859-4360-a6ff-8b692636cb35
Zobrazit plný text záznamu
8
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
Autor: José Thomas, Evert M. Noordijk, Saskia le Cessie, Flora E. van Leeuwen, J.H. Meerwaldt, Hanneke C. Kluin-Nelemans, Joke W. Baars, Patrice Carde, Martine Van Glabbeke, Elizabeth C. Moser
Publikováno v: Blood, 107(7), 2912-2919. AMER SOC HEMATOLOGY
Cardiovascular disease frequently occurs after lymphoma therapy, but it is common in the general population too. Therefore, risk estimation requires comparison to population -based rates. We calculated risk by standardized incidence ratios (SIRs) and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b91f32703dfd9dccd9d70dd01a5c5c
https://doi.org/10.1182/blood-2005-08-3392
Zobrazit plný text záznamu
9
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials
Autor: José Thomas, Evert M. Noordijk, Elizabeth C. Moser, Umberto Tirelli, J.H. Meerwaldt, Hanneke C. Kluin-Nelemans, Patrice Carde, Joke W. Baars, John M. M. Raemaekers, Martine Van Glabbeke, Dominique Bron
Publikováno v: Clinical Lymphoma & Myeloma, 6, 122-30
Clin.Lymphoma Myeloma., 6(2), 122-130
Clinical Lymphoma & Myeloma, 6, 2, pp. 122-30
Item does not contain fulltext BACKGROUND: A significant proportion of patients with aggressive non-Hodgkin's lymphoma (NHL) become long-term survivors. A European Organisation for Research and Treatment of Cancer database of patients with aggressive
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39f3077a271f18d4fc710aa291774ae
https://hdl.handle.net/2066/48648
Zobrazit plný text záznamu
10
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials
Autor: Evert M. Noordijk, J.M.M. Raemaekers, Johanna Kluin-Nelemans, Elizabeth C. Moser, M. van Glabbeke, I. Teodorovic, C De Wolf-Peeters, Patrice Carde, Umberto Tirelli, Joke W. Baars
Publikováno v: European Journal of Cancer, 40, 4, pp. 474-80
European Journal of Cancer, 40, 474-80
European Journal of Cancer, 40(4), 474-480. ELSEVIER SCI LTD
Item does not contain fulltext We analysed data from 936 newly-diagnosed patients with advanced, aggressive non-Hodgkin's lymphoma (NHL) treated in three randomised European Organisation for Research and Treatment of Cancer (EORTC) trials performed b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2225eb19ffd16598359479f6fadbe6d
https://doi.org/10.1016/j.ejca.2003.11.003
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje